Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and

U Keilholz, P Martus, CJA Punt, Wim Kruit, G Mooser, D Schadendorf, D Lienard, R Dummer, J (Julia) Koller, C Voit, Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

50 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1501-1511
Number of pages11
JournalEuropean Journal of Cancer
Volume38
Issue number11
DOIs
Publication statusPublished - 2002

Research programs

  • EMC MM-03-47-11
  • EMC MM-03-86-12

Cite this